Detalhe da pesquisa
1.
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Lancet
; 403(10435): 1460-1471, 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554725
2.
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.
Cancer
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470379
3.
Guiding principles on the education and practice of theranostics.
Eur J Nucl Med Mol Imaging
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453729
4.
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial.
Lancet Oncol
; 24(8): 892-902, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429302
5.
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.
Mol Cancer
; 22(1): 127, 2023 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37559050
6.
Pain in desmoid-type fibromatosis: Prevalence, determinants and prognosis value.
Int J Cancer
; 153(2): 407-416, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883417
7.
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
Br J Cancer
; 129(12): 1940-1948, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914801
8.
Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection.
Oncologist
; 28(7): 633-639, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971503
9.
Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial.
Ann Surg Oncol
; 30(13): 8653-8659, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777684
10.
Radioligand therapies in cancer: mapping the educational landscape in Europe.
Eur J Nucl Med Mol Imaging
; 50(9): 2692-2698, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058168
11.
Radiotherapy in bone sarcoma: the quest for better treatment option.
BMC Cancer
; 23(1): 742, 2023 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37563551
12.
Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC.
BMC Cancer
; 23(1): 69, 2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670431
13.
Prognostic factors of the synovial sarcoma of the extremities: imaging does matter.
Eur Radiol
; 33(2): 1162-1173, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35980435
14.
Prognostic Factors for Local Recurrence after Cryoablation of Desmoid Tumors.
J Vasc Interv Radiol
; 34(9): 1538-1546, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182669
15.
Wholistic approach: Transcriptomic analysis and beyond using archival material for molecular diagnosis.
Genes Chromosomes Cancer
; 61(6): 382-393, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35080790
16.
Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial.
Lancet Oncol
; 23(1): 53-64, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838156
17.
Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019.
Int J Cancer
; 151(8): 1345-1354, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603979
18.
Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group.
Int J Cancer
; 150(4): 645-653, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562271
19.
Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group.
Int J Cancer
; 150(5): 825-836, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611903
20.
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein in testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation study.
Int J Cancer
; 150(6): 993-1006, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724226